Discontinuation report LEVEMIR FLEXTOUCH
| Report ID | 182902 |
| Drug Identification Number | 02412829 |
| Brand name | LEVEMIR FLEXTOUCH |
| Common or Proper name | LEVEMIR FLEXTOUCH 5X3 ML |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN DETEMIR |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | EA |
| ATC code | A10AE |
| ATC description | INSULINS AND ANALOGUES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-07-31 |
| Actual discontinuation date | |
| Remaining supply date | 2023-07-01 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Patients who continue to have coverage for Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-02-01 | French | Compare |
| v1 | 2023-02-01 | English | Compare |
Showing 1 to 2 of 2